AIDA DURMISEVIC: Open Payments
NPI 1295115129 · NEW HARTFORD, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$857 in 31 payments from 13 companies in 2025. Trend: 2023 $1,570 · 2024 $1,126 · 2025 $857
Food & beverage: $708Education: $149
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 6 | $229 |
| ABBVIE INC. | 6 | $157 |
| AstraZeneca Pharmaceuticals LP | 5 | $95 |
| Merck Sharp & Dohme LLC | 3 | $81 |
| Janssen Biotech, Inc. | 3 | $74 |
| GENZYME CORPORATION | 1 | $36 |
| Geron Corporation | 1 | $31 |
| Eisai Inc. | 1 | $31 |
| Karyopharm Therapeutics Inc. | 1 | $27 |
| ARRAY BIOPHARMA INC | 1 | $26 |
Products named: Enhertu, KEYTRUDA, IMBRUVICA, CALQUENCE, SARCLISA, RINVOQ, VENCLEXTA, RYTELO.
Industry payments across NY — which companies pay providers there.
